Literature DB >> 3294208

A new caverno-spongiosum shunt with saphenous vein patch graft for established priapism.

E O Odelowo1.   

Abstract

Caverno-spongiosum shunt is the procedure of choice to achieve detumescence in established priapism before fibrosis of erectile tissue causes impotence. The corpora cavernosum and spongiosum, however, possess different suture holding properties. This results in excessive stretch of the urethra postoperatively. This caused a localized urethro-cutaneous fistula in one of our patients. A new technique for constructing the caverno-spongiosum shunt using autogenous saphenous vein patch graft in the remaining patients has been found to be more satisfactory than the conventional procedure. The new procedure, its advantages and its only drawback of increased operating time are described.

Entities:  

Mesh:

Year:  1988        PMID: 3294208

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  3 in total

Review 1.  What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel.

Authors:  S Minhas; A Salonia; M Gül; B Luca; K Dimitropoulos; P Capogrosso; U Milenkovic; A Cocci; R Veeratterapillay; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; A Kalkanli; M I Omar; C Bettocchi; J Carvalho; G Corona; T H Jones; A Kadioglu; J I Martinez-Salamanca; E C Serefoglu; P Verze
Journal:  Int J Impot Res       Date:  2022-08-08       Impact factor: 2.408

2.  Postpriapism erectile dysfunction and shunt-related urethral stricture: long-term morbidity after proximal shunt for ischaemic priapism.

Authors:  Jibril Oyekunle Bello
Journal:  Pan Afr Med J       Date:  2014-09-24

3.  Barry shunt for treatment of a 76-hour stuttering priapism without subsequent erectile dysfunction.

Authors:  Daniar Kurmanbekovich Osmonov; Aleksey Aksenov; Andrea Nathaly Guerra Sandoval; Almut Kalz; Klaus Peter Juenemann
Journal:  Res Rep Urol       Date:  2014-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.